Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reissue Patent
2007-09-11
2007-09-11
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200, C536S007400
Reissue Patent
active
11182038
ABSTRACT:
Compounds of the formulawhereinRais H; substituted or unsubstituted alkyl (1-10C); substituted or unsubstituted alkenyl (2-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20C); or ORais replaced by H;Rbis H or halogen;Rcis H or a protecting group;Rdis methyl, unsubstituted alkyl (3-10C); substituted alkyl (1-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20C); substituted or unsubstituted arylalkenyl (5-20C); substituted or unsubstituted arylalkynyl (5-20C); substituted or unsubstituted amidoarylalkyl (5-20C); substituted or unsubstituted amidoarylalkenyl (5-20C); or substituted or unsubstituted amidoarylalkynyl (5-20C);Reis H or a protecting group;L is methylene or carbonyl;T is —O—, —N(R)—, —N(OR)—, —N(NHCOR)—, —N(N═CHR)—, or —N(NHR)— wherein R is H or Raas defined above, with the proviso that when L is methylene, T is —O—;one of Z and Y is H and the other is OH, protected OH, or amino, mono- or dialkylamino, protected amino, or an amino heterocycle orZ and Y together are ═O, ═NOH or a derivatized oxime;including any pharmaceutically acceptable salts thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof, are antimicrobial agents.
REFERENCES:
patent: 5141926 (1992-08-01), Weber et al.
patent: 5527780 (1996-06-01), Agouridas et al.
patent: 5635485 (1997-06-01), Agouridas et al.
patent: 5672491 (1997-09-01), Khosla et al.
patent: 5747467 (1998-05-01), Agouridas et al.
patent: 5750510 (1998-05-01), Elliott et al.
patent: 5770579 (1998-06-01), Agouridas et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 6022965 (2000-02-01), Benedetti et al.
patent: 6043226 (2000-03-01), Lundy et al.
patent: 6066721 (2000-05-01), Khosla et al.
patent: 6080555 (2000-06-01), Khosla et al.
patent: 6121432 (2000-09-01), Bonnet et al.
patent: 6124269 (2000-09-01), Phan et al.
patent: 6271255 (2001-08-01), Leadlay et al.
patent: 6274560 (2001-08-01), Khosla et al.
patent: 6274715 (2001-08-01), Or et al.
patent: 6458771 (2002-10-01), Hlasta et al.
patent: 2754821 (1998-04-01), None
patent: WO-97/02358 (1997-01-01), None
patent: WO-97/42206 (1997-11-01), None
patent: WO-98/01546 (1998-01-01), None
patent: WO-98/01571 (1998-01-01), None
patent: WO-98/09978 (1998-03-01), None
patent: WO-99/03986 (1999-01-01), None
patent: WO-99/21871 (1999-05-01), None
patent: WO-99/35157 (1999-07-01), None
patent: WO-00/26224 (2000-05-01), None
patent: WO-00/26349 (2000-05-01), None
patent: WO-00/34297 (2000-06-01), None
patent: WO-00/44761 (2000-08-01), None
patent: WO-00/62783 (2000-10-01), None
patent: WO-00/71557 (2000-11-01), None
U.S. Appl. No. 60/117,631, O'Connell et al., filed Jan. 1999.
Weber et al., Science (1991) 252:114-117.
Ashley Gary
Chu Daniel
Kosan Biosciences, Inc.
Morrison & Foerster / LLP
Peselev Elli
LandOfFree
Macrolide antinfective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrolide antinfective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolide antinfective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798832